Hair Loss and GLP-1 Drugs
Recent Mendelian randomization study suggests that men predisposed to androgenetic alopecia may face an increased risk of hair loss when using GLP-1 drugs. This finding highlights the need for awareness among prescribers and patients regarding potential side effects of these medications related to hair health.
Prescription Trends for GLP-1
Data from Truveta indicated a 19% increase in GLP-1 prescribing among Medicare beneficiaries following the initiation of the Medicare GLP-1 Bridge program, suggesting greater accessibility and awareness of these treatments.
Product Recalls
The FDA has recalled Lipofit Extreme Fat Burner 2.0 due to contamination with undeclared fluoxetine and 2,4-dinitrophenol. This underlines the ongoing challenges in ensuring the safety of weight loss supplements on the market.
Estrogen Patch Supply Issues
Amid ongoing shortages, the FDA is collaborating with manufacturers to enhance the supply of estrogen patches, vital for hormonal therapy in numerous patients.
Safety Concerns with GLP-1 Formulations
The FDA has expanded its safety concerns related to unapproved GLP-1 formulations and highlights risks associated with multidose vials, emphasizing the importance of using approved medications.
Wegovy in Children
A recent phase III STEP Young trial reported that over 40% of children aged 6 to 11 years reversed their obesity status after 68 weeks of treatment with semaglutide (Wegovy), showing promising results for obesity management in younger populations.
Testosterone Screening Guidance
The Defense Department has temporarily rescinded its clinical guidance for mandatory testosterone deficiency screening in troops, demonstrating the complexities in managing hormonal health in military populations.
Effects of Semaglutide on Aging
In female mice, late-life administration of semaglutide has been linked to delayed biological aging indicators and extended lifespan, providing insights into potential anti-aging effects of this medication.
Insulin Affordability Advocacy
The Endocrine Society expressed support for the introduction of the INSULIN Act, aimed at improving insulin affordability, crucial for diabetic patients who rely on this hormone for managing their condition.
GLP-1 and Sleep Apnea
A review indicated that GLP-1 receptor agonists might serve as effective adjunctive therapy for obesity-related obstructive sleep apnea when combined with continuous positive airway pressure and other treatments.
Fitness Trackers Accuracy
Recent studies suggest that smartwatches may overestimate calorie burn during exercise, particularly in individuals with higher body fat, cautioning users about relying solely on these devices for accurate fitness tracking.
Gender-Affirming Care in Minors
An agreement with Mount Sinai in New York has resulted in the cessation of gender-affirming care for minors, raising significant ethical questions regarding access to such healthcare.
Adherence Challenges in Transgender Individuals
An online survey indicated that transgender and gender-diverse adults with autism face greater difficulties in adhering to gender-affirming hormone therapy, highlighting the need for tailored support in healthcare planning.
Disclaimer: The information provided in this article is for informational purposes only and should not be considered medical advice. Always consult a healthcare professional for personalized advice and treatment.
Fuente: https://www.medpagetoday.com/endocrinology/generalendocrinology/122927
Join the doctors who get the most relevant medical news, curated by specialty, every week — no spam, unsubscribe anytime.
